Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain stem gliomas.

J S Guillamo1, F Doz, J Y Delattre

  • 1Department of Neurology, Henri Mondor Hospital, Créteil, France.

Current Opinion in Neurology
|November 28, 2001
PubMed
Summary
This summary is machine-generated.

Brainstem gliomas are diverse tumors classified by patient age, symptoms, and tumor traits. This review covers subtypes in children and adults, plus new diagnostic and treatment approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinoblastoma: From genes to patient care.

European journal of medical genetics·2022
Same author

Imaging Features with Histopathologic Correlation of CNS High-Grade Neuroepithelial Tumors with a <i>BCOR</i> Internal Tandem Duplication.

AJNR. American journal of neuroradiology·2021
Same author

Brain radionecrosis with severe dementia occurring more than 20 years after radiotherapy: a case report.

Revue neurologique·2021
Same author

Focal Areas of High Signal Intensity in Children with Neurofibromatosis Type 1: Expected Evolution on MRI.

AJNR. American journal of neuroradiology·2020
Same author

Indications and results of diagnostic biopsy in pediatric renal tumors: A retrospective analysis of 317 patients with critical review of SIOP guidelines.

Pediatric blood & cancer·2019
Same author

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.

Journal of neuro-oncology·2017
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Neuro-oncology
  • Pediatric Oncology
  • Neuropathology

Background:

  • Brainstem gliomas are increasingly recognized as a heterogeneous group of neoplasms.
  • Tumor classification traditionally relies on factors like age at onset, clinical presentation, radiological imaging, and biological behavior.
  • Understanding this heterogeneity is crucial for effective management.

Purpose of the Study:

  • To provide a comprehensive overview of brainstem glioma subtypes.
  • To discuss recent advancements in diagnostic criteria for these tumors.
  • To review current and emerging therapeutic options for brainstem gliomas in both pediatric and adult populations.

Main Methods:

  • Literature review focusing on recent studies and clinical trials.
  • Synthesis of information on tumor classification, diagnostics, and therapeutics.

Related Experiment Videos

  • Comparative analysis of brainstem gliomas in children versus adults.

    • Main Results:

    • Brainstem gliomas exhibit significant variability, necessitating subtype-specific approaches.
    • Advances in molecular diagnostics are refining classification and identifying therapeutic targets.
    • Therapeutic strategies are evolving, incorporating targeted therapies and improved supportive care.

    Conclusions:

    • A nuanced understanding of brainstem glioma subtypes is essential for personalized medicine.
    • Continued research into diagnostic markers and novel treatments is critical for improving patient outcomes.
    • Multidisciplinary approaches are key to managing these complex tumors effectively.